[MO1] Mini-Oral Session 1　Lung Cancer / Thoracic Cancer 1（Cytotoxic）
【E】

[MO1-1] A Randomized Phase III Study of Carboplatin with Nab-Paclitaxel vs Docetaxel for elderly patients with Squamous NSCLC

^○Takayuki Suetsugu¹, Yoshihito Kogure², Akiko Kada³, Hiroya Hashimoto⁴, Shinji Atagi⁵, Yuichi Takiguchi⁶, Hideo Saka², Noriyuki Ebi⁷, Akira Inoue⁸, Takayasu Kurata⁹, Takeharu Yamanaka^10,11, Masahiko Ando¹², Tsuneo Shimokawa¹³, Norihiko Ikeda¹⁴, Hiroshige Yoshioka⁹, Takashi Abe¹⁵, Toshihide Yokoyama¹⁶, Nobuyuki Yamamoto¹⁷, Akihiko Gemma¹⁸ (1.Department of Respiratory Medicine, Sendai Medical Association Hospital, 2.Department of Respiratory Medicine, Nagoya Medical Center, 3.Clinical Research Center, National Hospital Organization Nagoya Medical Center, 4.Core Laboratory, Nagoya City University Graduate School of Medical Sciences, 5.Department of Thoracic Oncology, National Hospital Organization Kinki-Chuo Chest Medical Center, 6.Department of Medical Oncology, Graduate School of Medicine, Chiba University, 7.Department of Respiratory Medicine, Iizuka Hospital, 8.Department of Palliative Medicine, Tohoku University School of Medicine, 9.Department of Thoracic Oncology, Kansai Medical University Hospital, 10.Department of Biostatistics, Yokohama City University School of Medicine, 11.Department of Data Science, National Cancer Center Hospital East, 12.Department of Advanced Medicine, Nagoya University Hospital, 13.Department of Respiratory Medicine, Yokohama Municipal Citizen’s Hospital, 14.Department of Surgery, Tokyo Medical University,, 15.Pneumology, Ogaki Municipal Hospital, 16.Department of Respiratory Medicine, Kurashiki Central Hospital, 17.Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University, 18.Department of Pulmonary Medicine and Oncology, Nippon Medical School)